Clinical Trial Update: Post-marketing Surveillance for Hypertensive Patients With Diabetes and/or Chronic Kidney Disease

View source ↗

Summary

Post-marketing surveillance update from Bayer evaluating hypertensive patients, including those with diabetes and/or chronic kidney disease; the study status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus
• Hypertension

Snippet

Sponsor: Bayer | Conditions: Hypertension | Status: COMPLETED